Talcum Powder Cancer Lawsuit

The Modernization of Cosmetics Regulation Act of 2022 Grants The FDA Cosmetics Regulation Authority

People buying beauty and cosmetic products no longer risk that the ingredients in cosmetics may cause disease or permanent injury

Thursday, January 19, 2023 - Women are surprised and dismayed when they hear that the cosmetics that they are applying to their faces, and other beauty products they use have not been tested, approved, or regulated by the federal government. Most people assume that the US Food and Drug Administration (FDA) has the responsibility to keep dangerous cosmetic, health, and beauty care products off of the market, but they do not. The entire cosmetics industry is self-regulating meaning that the FDA merely issues guidance to each company and it is the company's responsibility to make sure their products do not harm consumer health. Back in 2020, during the height of the talcum powder cancer scandal, the cosmetics industry appeared to have dropped the ball regarding self-regulating when the FDA discovered asbestos in Johnson's Baby Powder. Asbestos is a known carcinogen found in the ground adjacent and sometimes overlapping or interspersed with talc. Many cosmetics sold by Claire's department stores to young women also have been tested and found to contain asbestos. Hidden deep with the, recently-passed omnibus spending bill was the Modernization of Cosmetics Regulation Act of 2022 which gives the FDA new powers to regulate the cosmetics industry.

Talc is the main ingredient in several types of cosmetics like foundations, blush, and other powders. The MOCRA is designed to increase consumer confidence in cosmetic products by requiring companies to test their talc-based products for asbestos, a known carcinogen. In light of the ongoing talcum powder lawsuits, the FDA has come under increasing pressure to insist that the cosmetics industry use stricter and standardized talc/asbestos testing methods. It is hoped that stricter testing will ensure talc-based cosmetics are free from the deadly carcinogen before going to market. The Modernization of Cosmetics Regulation Act is designed to accomplish just that ... to make sure that no talc that contains even the smallest possible amount of asbestos makes it to market. The increase in transparency of the cosmetics industry and their willingness to self-regulate will promote consumer confidence and increase sales of asbestos-free cosmetics.

Under The Act, companies must prove that their talc has been tested with the most modern methods and is asbestos-free. Companies may do so by acquiring a certificate of authenticity from their talc supplier or by testing it themselves. Companies must report any legal complaint or lawsuit against them to the FDA that involves an allegation of injury or death from using their talc-based cosmetics. The FDA has also been given recall authority over all cosmetics products and has the responsibility to do so if a product contains asbestos and thus is a consumer health risk. The FDA is required to publish a talc/asbestos database accessible to all consumers online to check the health status of the products they wish to use before using them. The database will list all complaints of adverse reactions from using a particular cosmetic item.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.